Key Drivers
- Strong Cash Generation
- Margin Compression
- Moderate Leverage
AIAI Summary
AMPH should be viewed less as a straightforward cheap cash generator and more as a business whose investment case now hinges on whether it can stabilize rebate pressure and reverse sharp margin compression before the lower-quality profit profile becomes permanent, even though strong free cash flow, liquidity, and buybacks still provide downside support.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Generation
- •Margin Compression
- •Moderate Leverage
AMPH posted strong full-year 2025 profitability and cash flow with solid liquidity, but recent quarterly margin compression and moderate leverage temper the outlook.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Weak support
- •Oversold bounce
AMPH is in a clear short-term downtrend, with lower highs/lows and failed rebounds, leaving only a possible oversold bounce from the $17-$18 support zone.
Sharp drop from a recent last month high on 2026-05-07 to a new period low signals a sudden momentum breakdown
Sentiment & News
Key News Insights:
- •EPS Miss
- •BAQSIMI Pressure
- •Revenue Outlook
Amphastar's Q1 results were mixed, with revenue holding up but adjusted EPS missing estimates amid ongoing BAQSIMI rebate and discount pressure, even as management kept its full-year revenue outlook intact.
The earnings miss and product-specific pricing pressure may weigh on sentiment, though reaffirmed revenue guidance helps limit downside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings